After watching this webinar, participants will know:

• which are the most important acute and subacute manifestations of cardiovascular toxicity in cancer therapy; and
• how to diagnose and manage myocarditis, heart failure, and cardiac arrhythmias secondary to cancer therapy.

Needs assessments:

• To acquire the knowledge and skills to manage the most important acute and subacute cardiovascular toxicity manifestations in cancer therapy. Due to publication of new cardio-oncology guidelines, there is an urgent need to align cardiology practices and to implement the new recommendations in the clinical setting.

See "more details" for subsequent webinar topics.

Main topic 

• Cardiovascular Disease in Special Populations

Related topic

• Cardio-Oncology

This webinar is part of the "2022 ESC Guidelines Series on Cardio-Oncology"

• What we need to know before cancer therapy 08/09/22
• Who needs cardiovascular surveillance after cancer treatment? 12/09/22
• How to manage cancer therapy-related cardiovascular toxicity 19/09/22
• How to organise cardiovascular monitoring during cancer treatment: who, when and how 26/09/22

For more focused information about the 2022 ESC Guidelines on Cardio-Oncology, please watch the following webinars:

• The role of cardiac imaging in the new 2022 ESC Guidelines on Cardio-Oncology. A joint webinar of EACVI / ESC Council of Cardio-Oncology 16/11/2022
• The role of cardiac imaging for assessment of specific patient populations, according to new 2022 ESC Guidelines on Cardio-Oncology. A joint webinar of EACVI / ESC Council of Cardio-Oncology - January 2023 (the date will be confirmed soon)

Discover the complete ESC Education offer on the 2022 Guidelines here

Session information

This webinar is designed for general cardiologist and trainees but also cardiologists wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.